Genetic Testing: 23andMe Gets FDA Clearance for Direct-to-Consumer Marketing of Personal Genome Service

 Email not displaying correctly? View it in your browser.
  Lab and Pathology Insider Logo  
January 15, 2019  
placeholder MARKETING
Genetic Testing: 23andMe Gets FDA Clearance for Direct-to-Consumer Marketing of Personal Genome Service
From - National Intelligence Report
The FDA is allowing direct-to-consumer marketing, with special controls, of the 23andMe Personal Genome Service Pharmacogenetic Reports test for genetic variants to detect…
Read More
placeholder EMERGING TESTS
Cytokines Could Predict Risk of Side Effects From Immunotherapy
From - Diagnostic Testing & Emerging Technologies
Blood-based cytokine markers may help identify cancer patients at greatest risk of developing side effects from immunotherapy treatment, according to…
Read More
placeholder NEW PRODUCTS
The Dx Pipeline: A Roundup of the Month's Key New Product Launches
From - Laboratory Industry Report
Here are some of the more notable launches from the busy October-November period…
Read More
placeholder LEGISLATION
New Broad All-Payor Kickback Law Impacting Laboratories, Commission-based Compensation and more
From - Lab Compliance Advisor
In a recent piece of federal legislation intended to address the opioid crisis across the United States, Congress enacted a new all-payor kickback law that applies to…
Read More

For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2019, All rights reserved.
Plain Language Media LLLP
PO Box 509, New London, CT 06320